Adventris Pharmaceuticals pricing

TL;DR: Adventris Pharmaceuticals does not publish a price list we can verify, which is normal for Healthcare companies at this stage. Below: what we can confirm, how to get a real quote, and 8 comparable tools to benchmark the number against.

What is verifiable about Adventris Pharmaceuticals pricing, how to get a real quote, and 8 comparable tools to price it against.

Company
Adventris Pharmaceuticals
Category
Healthcare
YC batch
Winter 2023
Status
Active
Team size
7
Public price list
Not published

Last verified:

Does Adventris Pharmaceuticals publish its pricing?

Not in any source we can verify. Adventris Pharmaceuticals is a Y Combinator-backed Healthcare company from the Winter 2023 batch, and companies at this stage usually quote per customer rather than publish rate cards. We will not guess at a number — anything quoted elsewhere without a source is guesswork too. The company profile we work from is the Y Combinator listing; the current figure has to come from Adventris Pharmaceuticals directly.

How to get an accurate Adventris Pharmaceuticals quote

  1. Ask for pricing at your actual volume, not the headline tier — per-seat and usage pricing diverge fast.
  2. Ask what happens at renewal. Uplift caps matter more than the first-year discount.
  3. Get the onboarding, migration and support costs in writing separately.
  4. Ask for a month-to-month option. If it does not exist, that tells you about the annual price.
  5. Quote a competitor from the table below. It is the fastest way to a real number.

Adventris Pharmaceuticals pricing compared to competitors

These are the closest comparable tools, matched on what Adventris Pharmaceuticals actually does. Price each one alongside it — stage and team size are a reasonable proxy for where a vendor sits on price.

Compare againstWhat it doesStageTeam
Biocogniv—YC Summer 20206
Docbot—YC Winter 2019—
Excepgen—YC Winter 20193
Mind Emulation Foundation—YC Winter 20181
ResistanceBioWe solve drug resistance for cancerYC Winter 201915
Avro Life ScienceSkin patches for generic drug delivery.YC Winter 20188
Atlas DiscoveryAI-native pharma companyYC Summer 20263
Synkrino BiotherapeuticsSynkrino's AI, SATIS is a powerful, unbiased discovery system for…YC Summer 20182

Is Adventris Pharmaceuticals worth the cost?

That depends on a number we cannot see, so judge it on what we can: Adventris Pharmaceuticals is currently Active with a team of around 7. A small team means faster support and more negotiating room, but more risk of the product changing direction. A larger or public vendor costs more and moves slower. If price is the deciding factor, the earlier-batch companies in the table are usually the ones still competing on it.

See all Adventris Pharmaceuticals alternatives compared →

Built by LemStudio

Building or buying SaaS? Try our founder tools →

Explore related

Loading interactive view…